Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia (Q33374227)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia (English)
1 reference
Aleksander Skotnicki
1 reference
Susan O'Brien
1 reference
Joseph O Moore
1 reference
Thomas E Boyd
1 reference
Loree M Larratt
1 reference
Benjamin Koziner
1 reference
Asher A Chanan-Khan
1 reference
John F Seymour
1 reference
R Gregory Bociek
1 reference
Steve Pavletic
1 reference
Kanti R Rai
1 reference
12 February 2007
1 reference
1 reference
Identifiers
1 reference